In a significant step forward for cancer immunotherapy, biotechnology company Pluri has announced a collaboration with Bar-Ilan University to advance MAIT cell therapy for solid tumors. The partnership, supported by the Israel Innovation Authority, brings together cutting-edge cellular technology with innovative genetic engineering to tackle one of medicine's most challenging frontiers: solid tumors.
As the global diabetes epidemic continues to escalate—quadrupling since 1980—the Russell Berrie Galilee Diabetes Social Precision-medicine Health Equity Research Endeavour (SPHERE) at Bar-Ilan University’s Azrieli Faculty of Medicine is tackling various aspects of this pressing international health crisis.
The announcement came at the start of the 2024-25 academic year, marking a significant shift in the university's strategic approach to industry collaboration.
The In-bar system manages all personal information for students, including all administrative and academic details.
The In-bar system allows you to:
BIU is launching an innovative learning tool: an AI-based learning assistant. A GPT natural language model that has been trained on course content, with whom students can talk regularly. If they missed a class, need additional explanationד, or seek information and clarification on assigned tasks, this assistant will immediately help them.
Israel's reputation as a hub for technological innovation is well-established. Ranking 7th in the 2021 Bloomberg Innovation Index, the country has consistently led the world in research intensity, spending a whopping 5.44% of its GDP on R&D in 2022. This culture of innovation has now set its sights on one of humanity's oldest challenges: aging.
